Agarikon As A Potential Smallpox Remedy – NPR Interview With Paul Stamets

May 14, 2010 | Posted by Dr. Markho Rafael

Interviewed on NPR, world leading medicinal mushroom specialist Paul Stamets relates how he came to discover the healing properties of agarikon, an increasingly rare wood conk that has all but vanished from Europe and now grows almost exclusively in the old growth rainforests of the northwestern United States.

Stamets knew that fungi (mushrooms) were more closely related to humans than to plants and therefore susceptible to many of the same pathogens (bacteria, molds, viruses). And yet the perennial agarikon mushroom managed to remain disease free in the dripping wet rainforests for up to 50 years without decaying from rot, mold, or bacteria. So therefore it followed, he figured, that it must possess a powerful immune system full of antibiotic compounds that might benefit people.

Agarikon in the wild looks somewhat like a beehive on the trunk of some of the giant, ancient trees of the old-growth forests of the American northwest. (See picture of Paul Stamets with one of these wood conks by clicking on the agarikon-link on this page.) Be aware that this is an endangered species, which should be left unharmed in the wild. But be sure to bring your digital camera so you can prove to your mushroom club friends that you saw it.

Paul Stamets now grows his own agarikon, which he uses for his agarikon extract. A sample of this extract was sent to the BIO Shield Program for testing at a top security lab located in Ft. Dietrich, MD. The BIO Shield Program is a division within the Defense Department created to search for remedies against biological warfare agents and bioterrorism threats – e.g. pathogens like smallpox or anthrax.

Reportedly, tens of thousands of natural as well as manmade remedies are tested through the BIO Shield Program. According to drug discovery supervisor John Seacrest, Paul Stamets agarikon extract scored one of the rare hits against viruses related to smallpox. In other words, it effectively inhibited smallpox related viruses under lab conditions.

Following this discovery, Paul Stamets now has a patent pending on a mushroom-derived anti-viral drug. One of his financial backers, Boston-based investor John Norris, bases his support in part on the fact that, as he says, not everyone is able or willing to be vaccinated against diseases such as smallpox.

As a former second at the FDA, John Norris should know enough about the field of medicine. And obviously, his belief in Paul Stamets agarikon extract is strong enough to put his money where his mouth is. His goal is that they may someday sell this agarikon extract for the defense stock-piles of NATO armies, with doses numbering in the hundreds of millions.

That may still be a few years into the future, though. Paul Stamets new mushroom related anti-viral medicine first has to stand up to exhaustive testing, and then eventually be approved for release by the FDA.

Note: This article is intended to provide entertainment and information only. Do not use this or any other herbal or mushroom-based product for medicinal purposes unless advised by a licensed medical doctor.

Reference: Banse, T., NPR Morning Edition, Smallpox Defense May Be Found in Mushrooms, August 4, 2005.

About the author: Dr. Markho Rafael has worked with natural health products since 1996, specializing in medicinal mushrooms. Click Agarikon Mushroom for agarikon-photo, mushroom products, free mushroom articles, or to request a unique copy of any mushroom article for your own web-site or magazine / ezine. Click Fomitopsis medicinal for scientific research references about agarikon.